Pteridine derivatives as nitric oxide synthase activators

Wadsworth, R. (2005) Pteridine derivatives as nitric oxide synthase activators. A61K 31/525.

Abstract

The present invention relates to the use of pteridine derivatives as nitric oxide synthase activators. In particular, the derivatives find use in the treatment of diseases associated with endothelial dysfunction such as cardiovascular diseases.

ORCID iDs

Gibson, C.L. ORCID: https://orcid.org/0000-0003-4948-1266

• Share and Export
  

  RDF+XMLBibTeXRIOXX2 XMLRDF+N-TriplesJSONDublin CoreAtomSimple MetadataReferMETSHTML CitationASCII CitationOpenURL ContextObjectEndNoteOpenURL ContextObject in SpanMODSMPEG-21 DIDLEP3 XMLData Cite XMLRIS (EndNote Online, Zotero, Ref manager, etc)RDF+N3Multiline CSV
• Citations and altmetrics
• Item metadata

  Item type:	Patent
  ID code:	39104
  Dates:	Date Event 2005 Published
  Keywords:	pteridine, cardiovascular disease, endothelial dysfunction, Chemistry, SDG 3 - Good Health and Well-being
  Subjects:	Science > Chemistry
  Department:	Faculty of Science > Pure and Applied Chemistry Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
  Depositing user:	Pure Administrator
  Date deposited:	12 Apr 2012 08:44
  Last modified:	18 Jan 2023 12:05
  Related URLs:	Journal or Publication
  URI:	https://strathprints.strath.ac.uk/id/eprint/39104